Search

Your search keyword '"Ueda, Yutaka"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Ueda, Yutaka" Remove constraint Author: "Ueda, Yutaka" Topic endometrial neoplasms Remove constraint Topic: endometrial neoplasms
39 results on '"Ueda, Yutaka"'

Search Results

1. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.

2. Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.

3. Postoperative lymphocyst formation after pelvic lymphadenectomy for gynecologic cancers: comparison between laparoscopy and laparotomy.

4. Improved long-term survival of corpus cancer in Japan: A 40-year population-based analysis.

5. Endometrial carcinoma in a gravid uterus: a case report and literature review.

6. A successful intraoperative diagnosis of coexisting lymphoma and endometrial cancer.

7. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.

8. Association of statins, aspirin, and venous thromboembolism in women with endometrial cancer.

9. A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2).

10. Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.

11. Assessment of Myometrial Invasion in Premenopausal Grade 1 Endometrial Carcinoma: Is Magnetic Resonance Imaging a Reliable Tool in Selecting Patients for Fertility-Preserving Therapy?

12. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.

13. Total laparoscopic hysterectomy for endometrial cancer in a renal transplantation patient receiving peritoneal dialysis: Case report and literature review.

14. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer.

15. Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer.

16. Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas.

17. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis.

18. Long-term survival in small-cell carcinoma of the endometrium with liver and brain metastases.

19. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia.

20. CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.

21. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.

22. Endometrial adenocarcinoma arising in a Turner's syndrome patient with spontaneous menstruation: a case report.

23. Endometrial thickness measured by ultrasonography in postmenopausal patients with endometrial carcinoma has significance, irrespective of histological subtype.

24. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.

25. [Genetic diagnosis of the endometrial cancer].

26. Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma.

27. Dissection of unsuspicious para-aortic lymph nodes does not improve prognosis of advanced endometrial carcinoma with intra- or extra-abdominal metastasis.

28. Chemotherapy for endometrial carcinoma (GOGO-EM1 study): TEC (paclitaxel, epirubicin, and carboplatin) is an effective remission-induction and adjuvant therapy.

29. Intraoperative frozen section assessment of myometrial invasion and histology of endometrial cancer using the revised FIGO staging system.

30. Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later.

31. Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin.

32. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.

33. Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma.

34. Endometrial carcinoma: better prognosis for asymptomatic recurrences than for symptomatic cases found by routine follow-up.

35. Prognostic significance of CUB domain containing protein expression in endometrioid adenocarcinoma.

36. Endometrial carcinoma with extra-abdominal metastasis: improved prognosis following cytoreductive surgery.

37. Frequent inactivation of RUNX3 in endometrial carcinoma.

38. Clonality and HPV infection analysis of concurrent glandular and squamous lesions and adenosquamous carcinomas of the uterine cervix.

39. Altered protein expression in endometrial carcinogenesis.

Catalog

Books, media, physical & digital resources